JY
NSPR icon

Jeff Yass’s InspireMD NSPR Stock Holding History

Jeff Yass’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Buy
+20,594
New +$21.8K ﹤0.01% 13090
2023
Q4 		– Sell
-24,716
Closed -$81.1K – 13000
2023
Q3 		$81.1K Buy
+24,716
New +$78.9K ﹤0.01% 11064
2022
Q4 		– Sell
-15,730
Closed -$23K – 13276
2022
Q3 		$23K Buy
+15,730
New +$28.7K ﹤0.01% 12553
2022
Q2 		– Sell
-13,103
Closed -$42K – 13602
2022
Q1 		$42K Buy
13,103
+2,292
+21% +$6.35K ﹤0.01% 12385
2021
Q4 		$33K Buy
+10,811
New +$40.6K ﹤0.01% 12718
2020
Q4 		– Sell
-1,086
Closed -$5K – 11502
2020
Q3 		$5K Sell
1,086
-456
-30% -$2.89K ﹤0.01% 10442
2020
Q2 		$11K Buy
+1,542
New +$15.7K ﹤0.01% 9975
2016
Q4 		– Hold
0
– -$15K – 9950
2016
Q3 		– Hold
0
– – – 8267
2015
Q3 		– Hold
0
– -$15K – 9986
2015
Q2 		– Hold
0
– – – 10018
2015
Q1 		– Hold
0
– – – 9333

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Jeff Yass's NSPR Position: Q2 2026 in Review

Jeff Yass opened a new position in InspireMD (NSPR) in Q2 2026: 20,594 shares worth $14.4K. The stake represents ﹤0.01% of the portfolio and ranks #13090 among its holdings. This is a return to the name: Jeff Yass previously reported a position in NSPR as recently as Q3 2023.

Jeff Yass first reported a position in NSPR in Q2 2020 and has held it in 7 quarters since. The position peaked at $81.1K in Q3 2023. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Jeff Yass held 20,594 shares of InspireMD worth $14.4K as of Q2 2026.
  • InspireMD was a new Jeff Yass position in Q2 2026.
  • InspireMD made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13090 holding.
  • Jeff Yass first reported a position in InspireMD in Q2 2020 and has held it in 7 quarters since.
  • Jeff Yass's InspireMD position peaked at $81.1K in Q3 2023.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.